Enterome
Privately owned personalized medicine company
Total raised
€78M
€77,718,460
Funding rounds
4
Investors
5
distinct backers
Active since
2012-02
latest 2025-06
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood28
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 19y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-12 | Other | €16M | existing specialist investors,The Institute for Follicular Lymphoma Innovation (IFLI) ,The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) | View deal → |
| 2020-06-25 | Series D+ | €46M | — | View deal → |
| 2014-05-01 | Other | €10M | Omnes Venture Capital | View deal → |
| 2012-03-01 | Series A | €5.0M | Seventure Partners | View deal → |
Investors
5Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software